Eureka Therapeutics
PrivateLast Round
Grant
Jun 6, 2023
Total Funding Raised
$136.6M
Company Overview
Eureka Therapeutics is a biotechnology company that develops novel T-cell therapies and antibody-drug discovery technology for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eureka Therapeutics Comparables
Compare Eureka Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crossbow Therapeutics | 82% | |
| Oricell Therapeutics | 81% | |
| A2 Biotherapeutics | 80% | |
Eureka Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 6, 2023 | ||||
| Series E | Mar 17, 2020 | ||||
| Series D | Jan 22, 2018 | ||||
| Series C | Sep 23, 2014 |
Eureka Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Acorn Campus Ventures | Series D, Series C |
| Suma Venture | Series C, Series D |
| California Institute for Regenerative Medicine | Grant |
| Yuan Capital | Series D, Series C |
| Harbinger Venture Capital | Series C, Series D |
| 金浦产业投资基金管理有限公司 | Series D |
| Acorn Pacific Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Added Iwai Chem, a chemicals/distribution SMB, as a customer.
- Aug 12, 2025
William S. Solari III has joined the Board of Directors.
Eureka Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eureka Therapeutics's valuation, stock price, and market status.